ANA Testing as Routine Diagnostic Work-Up of Women Experiencing REPL – RBMO
Reproductive BioMedicine Online (RBMO) shared a post on LinkedIn about a paper by Valerie Uvin et al. published in RBMO:
“This new study examines the prevalence of antinuclear antibodies (ANAs) in women with recurrent early pregnancy loss (REPL), and whether they affect subsequent pregnancy outcomes.
The data presented by the author team led by Valerie Uvin at Vrije Universiteit Brussel, indicates that there is no higher prevalence of ANA positivity in women experiencing REPL.
The authors say ‘We believe there is currently insufficient evidence to incorporate or withhold ANA testing in the routine diagnostic work-up of women experiencing REPL in the absence of clinical signs of a systemic autoimmune disease. In addition, we were unable to demonstrate any significant impact of ANA positivity on the outcome of a subsequent pregnancy. Taken together, these findings do not support the current common practice of routine ANA testing in women with REPL, nor the use of (immunologic) add-on treatments in the presence of ANA positivity. Rather, they provide reassurance that ANA positivity alone does not justify additional interventions outside a research setting.’
RBMO subscribers can read the full paper from our in-press articles section now․”
Title: Antinuclear antibodies in women with recurrent early pregnancy loss: prevalence and impact on subsequent pregnancy outcome
Authors: Valerie Uvina, Lieve Lernera, Karin Melsensb, Simke Demeesterc, Ronald Buyld, Corinne Evers-lebrunb, Michael De Bruckera, Herman Tournayea, David Unuanef, Shari Mackensa
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
May 13, 2026, 16:24Shanza Ghaffar: Recurrent Pregnancy Loss Beyond Diagnosis and Treatment
-
May 13, 2026, 16:16Alejandro González: A Historic Moment for the PCOS Community
-
May 13, 2026, 16:15Antonio La Marca: Where There Is Research, There Is Better Care
-
May 13, 2026, 16:06Mirjam Teboe: APS Diagnosis Faces False Positive Challenges in Lupus Anticoagulant Testing
-
May 13, 2026, 16:03The Link Between Lifestyle and Environmental Exposures and Endometriotic Phenotype – RBMO
-
May 13, 2026, 11:42Analysis of MED-12 Mutations in Uterine Leiomyomas of Nigerian Women – Fertility and Sterility
-
May 13, 2026, 11:33Anuja Dokras: SPIRE 2026 Brings Together the Global Fertility Community
-
May 13, 2026, 11:23Sean Lauber: Why Do Aneuploid Embryos Rarely Lead to Live Births?
-
May 13, 2026, 10:40Polyendocrine Metabolic Ovarian Syndrome, the New Name for PCOS – PCOS Awareness Association